Final ID: 4362907
Hernandez-pastrana Sarai, Latapi Ruiz Esparza Ximena, Martignoni Felipe, Araiza Diego, Doma Mohamed, Fatima Syeda Rubab, Hemdanieh Maya, Kritya Mangesh, Huang Wilbert, Naji Zahra, Lingamsetty Shanmukh Sai Pavan, Gewehr Douglas
A First-In-Human Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REGN7544, a Novel Natriuretic Peptide Receptor 1–Blocking Monoclonal AntibodyAhmed Mohsin, Morton Lori, Olenchock Benjamin, Herman Gary, Wynne Chris, Marin Ethan, Tuckwell Katie, Xu Meng, Cheng Xiping, Redington Emily, Koyani Bharatkumar, Mateo Katrina, Thakur Mazhar, Devalaraja-narashimha Kishor